We have an amazing arsenal of medications today compared to 10 or 15 years ago, including beneficial classes beyond GLP-1s and GLP-1/GIPs, such as Qsymia (phentermine + topiramate), Contrave (naltrexone + bupropion), and metformin
Understanding who should not take GLP-1 is just as important as knowing who benefits most
However, another consequence may be that upon duplication, some of the new gene copies, which have been less subject to evolutionary pressure and have accumulated mutations, have likely acquired structural and functional diversity
Knowing which one might suit us best means diving into the trials, side effects, and practical details
Gentle adjustments reduce pressure on nerves and improve the range of motion
And there were only 13 people